A study has reported results of a clinical trial using CAR-T therapy where over half of the cancer patients were alive two year after the start...
The post Global 2-year trial reports on CAR-T therapy to treat DLBCL appeared first on European Pharmaceutical Review.
Original Article: Global 2-year trial reports on CAR-T therapy to treat DLBCL